NIDAN LABORATORIES...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO NIDAN LABORATORIES...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Nidan Laboratories & Healthcare Ltd.

Nidan Laboratories & Healthcare Ltd.

NSE SME · SME IPO
Listed NSE SME SME Live Chart
Issue Price
₹125
₹125
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹125
Based on GMP
Min. Investment
₹125,000
1 lot × 1000 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
28 Oct 2021
Close Date
02 Nov 2021
Allotment
09 Nov 2021
Listing Date
12 Nov 2021
Exchange
NSE SME
Price Band
₹125
Listing Price
See chart
Allotment Status
Price Band
₹125
Per share
Face Value
₹10 per share
 
Lot Size
1,000 Shares
per lot
Issue Size
40,00,000 shares (aggregating up to ₹50.00 Cr)
Total offering
Issue Type
Fixed Price IPO
 
Min Investment
₹125,000
1 lot
Pre-IPO Holding
99,00,000 shares
Promoters
Post-IPO Holding
1,39,00,000 shares
Promoters
UPI Deadline
2021-11-02
Mandate
Anchor AllotmentWed, 27 Oct 2021
Basis of AllotmentTue, 09 Nov 2021
Refund InitiationWed, 10 Nov 2021
Demat CreditThu, 11 Nov 2021
Listing DayFri, 12 Nov 2021
UPI Mandate Deadline2021-11-02
Sale TypeFresh Capital
Net Offer to Public38,00,000 shares (aggregating up to ₹47.50 Cr)
Market Maker Quota2,00,000 shares (aggregating up to ₹2.50 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Nidan Laboratories & Healthcare Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 02 Nov 2021.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
Market Maker
Awaited
200,000
₹2.50
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
4,000,000
100% ₹50.00
IPO Shares Offered
Nidan Laboratories & Healthcare Ltd. IPO total issue size: ₹50.00 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Market Maker 200,000 ₹2.50
5.00%
Total 4,000,000 ₹50.00
100.00%
* Based on upper price band ₹125 per share
Lot Size & Investment
Lot Size
1,000
Shares per Lot
Issue Price
₹125.00
Upper Band
Min Investment
₹125,000
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)22,000₹250,000
Retail (Max — 13 Lots)1313,000₹1,625,000
S-HNI (Min — 14 Lots)1414,000₹1,750,000
B-HNI (Min — 68 Lots)6868,000₹8,500,000
* Issue Price ₹125 × Lot Size 1,000 shares
IPO Schedule
Anchor
27 Oct 2021
✓ Done
IPO Open
28 Oct 2021
✓ Done
IPO Close
02 Nov 2021
✓ Done
Allotment
09 Nov 2021
✓ Done
Refunds
10 Nov 2021
✓ Done
Demat Credit
11 Nov 2021
✓ Done
Listing Day
12 Nov 2021
✓ Done
Nidan Laboratories & Healthcare Ltd. — Live Price LIVE
₹125.00
INR · NSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹125.00 Live Price
About Nidan Laboratories & Healthcare Ltd.
Incorporated in the year 2000, Nidan Laboratories and Healthcare Limited offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. As of March 31, 2021, the company offered approximately 740 routine and 3000 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The company also offers a broad spectrum of customized health and wellness packages to its customers and offers value-added services to its customers such as a home collection of specimens, house calls, and various delivery or access modes for test reports.Nidan has come out with a unique appointment booking mobile application under the name of "NIDAN HEALTHCARE" which is supported by self-indigenous software called "Nidan Operation Management (NOM)." This unique app enables patients to book appointments for any test, from anywhere, at any time. The company has also tied up with pathology partners like Metropolis Laboratories Limited for its services.Out of the 35 centers operating under the brand name of "Nidan Healthcare", 16 centers are under the Franchisee model where 1 center acts as a fully operated diagnostic center and 15 centers act solely as standalone collection centers. As of June 30, 2021, the company had a total of 213 employees. The company has got recognitions like the Best Diagnostic Chain of India Award 2019, in the Category of 20+ diagnostic centers by Express Healthcare.Competitive Strengths:Trusted, high quality, and reliable brand name.Customer-centric approach & servicesLocation benefitsWide range of diagnostic services at affordable pricesRobust IT technical capabilities with strong IT infrastructureStrong and experienced leadership with a dedicated management team
Objects of the Issue
1
1 Repayment of Loans
2
2 Additional Working Capital
3
3 General Corporate Expenses
4
4 To meet the expenses of the Issue
Nidan Laboratories & Healthcare Ltd. Financials (Amount in Crore)
Revenue from Operations
₹22.2
31-Mar-20
₹21.9
31-Mar-21
₹7.9
30-Jun-21
Profit After Tax (PAT)
₹0.7
31-Mar-20
₹2.3
31-Mar-21
₹1.1
30-Jun-21
Particulars30-Jun-2131-Mar-2131-Mar-20
Revenue from Operations 7.85 21.85 22.19
EBITDA N/A N/A N/A
Profit After Tax (PAT) 1.09 2.30 0.71
Net Worth N/A N/A N/A
Total Assets 54.33 52.44 45.21
Reserves & Surplus N/A N/A N/A
Borrowings N/A N/A N/A
EBITDA Margin (%) N/A
PAT Margin (%) N/A
Issue Structure & Shareholding
Total Shares Offered40,00,000 (100.00%)
Net Offer to Public38,00,000 shares (aggregating up to ₹47.50 Cr)
Reserved for Market Maker2,00,000 shares (aggregating up to ₹2.50 Cr)
Pre-Issue Promoter Holding99,00,000 shares
Post-Issue Promoter Holding1,39,00,000 shares
P/BV RatioN/A
RoEN/A
RoCEN/A
Debt / EquityN/A
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
First Overseas Capital Ltd.
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Nidan Laboratories & Healthcare Ltd. IPO subscribed?

Nidan Laboratories & Healthcare Ltd. IPO is subscribed 1.00 times by Nov 02, 2021. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Nidan Laboratories & Healthcare Ltd. IPO retail subscription status?

The Nidan Laboratories & Healthcare Ltd. IPO retail category is subscribed 1.00 times as of 02 Nov 2021. The retail portion is oversubscribed.

How to subscribe Nidan Laboratories & Healthcare Ltd. IPO?

Subscribe via your broker app using ASBA or UPI. Opens 28 Oct 2021 and closes 02 Nov 2021. Min investment: ₹125,000 (1 lot = 1,000 shares). UPI mandate: 2021-11-02.

How many times Nidan Laboratories & Healthcare Ltd. IPO subscribed?

The Nidan Laboratories & Healthcare Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Nidan Laboratories & Healthcare Ltd. IPO allotment?

Check allotment on the registrar website (Bigshare Services Pvt.Ltd.) at https://ipo.bigshareonline.com/IPO_Status.html. Enter your PAN, application number or DP/Client ID. Allotment date: 09 Nov 2021. Refunds: on 10 Nov 2021.

When Nidan Laboratories & Healthcare Ltd. IPO will be listed?

The Nidan Laboratories & Healthcare Ltd. IPO listing date is 12 Nov 2021, Friday. Listed on: NSE SME. Issue price: ₹125. Estimated listing: ₹125. GMP: NIL.

When Nidan Laboratories & Healthcare Ltd. IPO close?

The Nidan Laboratories & Healthcare Ltd. IPO closes on 02 Nov 2021, Tuesday. UPI mandate: 2021-11-02. Allotment: 09 Nov 2021. Listing: 12 Nov 2021.